SCHEMBL5115210

SCHEMBL5115210

CCc1ccc(S(=O)(=O)O)cc1S(=O)(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
HSD17B10 Q99714 5/20 0.41
CASP6 P55212 2/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
LMNA P02545 2/20 0.40
TSHR P16473 3/20 0.39
NT5E P21589 1/20 0.39
TIMP3 P35625 1/20 0.39
HPGD P15428 2/20 0.39
HIF1A Q16665 1/20 0.39
TDP1 Q9NUW8 2/20 0.38
PTPN11 Q06124 1/20 0.38
KDM4E B2RXH2 1/20 0.38
S1PR3 Q99500 1/20 0.38
SNCA P37840 1/20 0.38
SFRP1 Q8N474 2/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15984418 0.87 HSD17B10 (0.39) ALDH1A1HSD17B10CASP6CYP2C9CYP2C19
SCHEMBL2523959 0.84 ALDH1A1 (0.41) ALDH1A1HSD17B10CASP6CYP2C9CYP2C19
SCHEMBL1806779 0.84 ALDH1A1 (0.41) ALDH1A1HSD17B10CASP6CYP2C9CYP2C19
SCHEMBL1806781 0.84 ALDH1A1 (0.41) ALDH1A1HSD17B10CASP6CYP2C9CYP2C19
SCHEMBL27816835 0.84 S1PR3 (0.43) ALDH1A1HSD17B10CASP6CYP2C9CYP2C19
SCHEMBL18745553 0.83 POLB (0.42) ALDH1A1LMNATSHRHPGDSFRP1
SCHEMBL6429457 0.82 ALDH1A1 (0.40) ALDH1A1HSD17B10CASP6CYP2C9CYP2C19
SCHEMBL10577881 0.82 ALDH1A1 (0.40) ALDH1A1HSD17B10CASP6CYP2C9CYP2C19
SCHEMBL20854288 0.82 ALDH1A1 (0.40) ALDH1A1HSD17B10CASP6CYP2C9CYP2C19
SCHEMBL1804271 0.82 TIMP3 (0.41) ALDH1A1HSD17B10CASP6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11376272-B2 Methods of modulating immune activity FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) 2022-07-05 US disclosed
US-11180657-B2 Polysulfonated fluorescence dyes ATTO-TEC GMBH (DE) 2021-11-23 US disclosed
US-20210299155-A1 METHODS OF MODULATING IMMUNE ACTIVITY FLAGSHIP PIONEERING INNOVATIONS V, INC. 2021-09-30 US disclosed
EP-3461815-B1 NOVEL POLY SULFONATED FLUORESCENCE DYES ATTO TEC GMBH (DE) 2021-03-03 EP disclosed
US-20190322870-A2 NOVEL POLYSULFONATED FLUORESCENCE DYES ATTO-TEC GMBH (DE) 2019-10-24 US disclosed
US-20190100653-A1 NOVEL POLYSULFONATED FLUORESCENCE DYES ATTO-TEC GMBH (DE) 2019-04-04 US disclosed
EP-3461815-A1 NOVEL POLY SULFONATED FLUORESCENCE DYES ATTO-TEC GmbH (DE) 2019-04-03 EP disclosed
US-8647880-B2 Mass spectrometry-based protein identification method with selective N-terminus derivatization Rudjer Bosckovic Institute (HR) 2014-02-11 US disclosed
US-20110212531-A1 Mass Spectrometry-Based Protein Identification Method RUDJER BOSKOVIC INSTITUTE (HR) 2011-09-01 US disclosed
US-7456321-B2 Process for producing high-purity 4,4′-dihydroxydiphenyl sulfone KONISHI CHEMICAL IND. CO., LTD. (JP) 2008-11-25 US disclosed
CN-1314664-C Process for producing high-purity 4,4'-dihydroxydiphenyl sulfone KONISHI CHEM IND (JP) 2007-05-09 CN disclosed
US-20050272956-A1 Process for producing high-purity 4,4'-dihydroxydiphenyl sulfone KONISHI CHEMICAL IND. CO., LTD. (JP) 2005-12-08 US disclosed
CN-1684943-A Process for producing high-purity 4,4'-dihydroxydiphenyl sulfone KONISHI CHEM IND (JP) 2005-10-19 CN disclosed
EP-0443046-B1 PROCESS FOR PREPARING 4,4'-DIHYDROXYDIPHENYL SULFONE KONISHI CHEM IND (JP) 1994-04-13 EP disclosed
US-5189223-A PROCESS FOR PREPARATION OF 4,4'-DIHYDROXYDIPHENYLSULFONE KONISHI CHEMICAL IND. CO., LTD. (JP) 1993-02-23 US disclosed
EP-0443046-A1 PROCESS FOR PREPARING 4,4'-DIHYDROXYDIPHENYL SULFONE KONISHI CHEMICAL IND. CO., LTD. (JP) 1991-08-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11376272-B2 Methods of modulating immune activity STING1, IRF3, CGAS ALDH1A1 4487/4885HSD17B10 4810/4885CASP6 1992/4885
US-11180657-B2 Polysulfonated fluorescence dyes CD44, ARSA, STS ALDH1A1 199/4885HSD17B10 2302/4885CASP6 1929/4885
US-20210299155-A1 METHODS OF MODULATING IMMUNE ACTIVITY STING1, IRF3, CGAS ALDH1A1 4549/4885HSD17B10 4832/4885CASP6 2024/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.